Related Experiment Video

Updated: Apr 13, 2026

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

11.6K

First pertussis vaccine dose and prevention of infant mortality

Tejpratap S P Tiwari1, Andrew L Baughman2, Thomas A Clark3

  • 1Meningitis and Bacterial Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, and tit2@cdc.gov.

Pediatrics
|May 6, 2015
PubMed

Insights

Pertussis vaccination and early antibiotic treatment significantly reduce infant deaths and severe illness. These interventions are crucial for protecting vulnerable infants from pertussis complications.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Vaccinology

Background:

  • American infants face the highest risk of severe pertussis and mortality.
  • Pertussis (whooping cough) remains a significant threat to young infants.

Purpose of the Study:

  • To investigate the protective role of pertussis vaccination in preventing infant deaths.
  • To identify risk markers for mortality among infants under 42 days old.

Main Methods:

  • Analysis of national infant pertussis cases (fatal and nonfatal) from 1991-2008.
  • Categorization of infants based on eligibility for the first pertussis vaccine dose at 6 weeks.
  • Multivariable logistic regression to assess the impact of vaccination on outcomes.

Main Results:

  • Vaccination with at least one dose significantly reduced death, hospitalization, and pneumonia in infants over 42 days.
  • Hispanic and American Indian/Alaska Native infants showed elevated risk.
  • Recommended antibiotic treatment was associated with lower risk of adverse outcomes.

Conclusions:

  • The initial dose of the pertussis vaccine is protective against severe outcomes.
  • Prompt antibiotic treatment is vital for reducing pertussis-related mortality and morbidity in infants.
Abstract

More Related Videos

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice06:32

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Published on: September 19, 2016

11.2K
Myelin Oligodendrocyte Glycoprotein MOG35-55 Induced Experimental Autoimmune Encephalomyelitis EAE in C57BL/6 Mice08:03

Myelin Oligodendrocyte Glycoprotein MOG35-55 Induced Experimental Autoimmune Encephalomyelitis EAE in C57BL/6 Mice

Published on: April 15, 2014

84.6K

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
54.6K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
868
Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
124
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
2.2K
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
4.0K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
922